Sagimet Biosciences Inc. (SGMT)
NASDAQ: SGMT · Real-Time Price · USD
8.80
-0.13 (-1.46%)
At close: Oct 12, 2026, 4:00 PM EDT
8.72
-0.08 (-0.91%)
Pre-market: Oct 13, 2026, 8:48 AM EDT
Sagimet Biosciences Stock Forecast
Stock Price Forecast
According to 12 analysts polled by S&P Global, Sagimet Biosciences stock has a consensus rating of "Buy" and an average price target of $27.91. The average 1-year stock price forecast is 217.16% higher than the current stock price, while the lowest is $7.00 (-20.45%) and the highest is $56 (+536.36%).
Price Target: $27.91 (+217.16%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Sagimet Biosciences stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 8 | 8 | 8 | 8 | 9 | 9 |
| Buy | 1 | 1 | 1 | 1 | 2 | 2 |
| Hold | 1 | 1 | 1 | 1 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 1 | 1 |
| Total | 10 | 10 | 10 | 10 | 12 | 12 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $29 | Buy | Reiterates | $29 | +229.55% | Oct 5, 2026 |
| Guggenheim | Guggenheim | Buy Reiterates $25 → $26 | Buy | Reiterates | $25 → $26 | +195.45% | Oct 2, 2026 |
| Leerink Partners | Leerink Partners | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Oct 1, 2026 |
| Goldman Sachs | Goldman Sachs | Sell Maintains $7 | Sell | Maintains | $7 | -20.45% | Oct 1, 2026 |
| Oppenheimer | Oppenheimer | Buy Maintains $33 → $38 | Buy | Maintains | $33 → $38 | +331.82% | Oct 1, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
8.47M
EPS This Year
-1.12
from -1.58
EPS Next Year
-1.30
from -1.12
EPS and Forward PE are based on non-GAAP adjusted numbers.